|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Capitalization1 |
26 926 | 17 380 | 19 672 | 19 974 | 16 742 | 10 754 | - | - |
Enterprise Value (EV)1 |
33 395 | 22 780 | 32 447 | 31 272 | 28 580 | 22 298 | 21 868 | 21 274 |
P/E ratio |
21,1x | 8,75x | 16,7x | 17,2x | 17,3x | 15,8x | 10,7x | 8,65x |
Yield |
1,09% | 2,07% | 1,82% | 1,96% | 2,36% | 3,00% | 3,45% | 3,94% |
Capitalization / Revenue |
1,51x | 1,05x | 1,13x | 1,12x | 0,95x | 0,56x | 0,54x | 0,51x |
EV / Revenue |
1,88x | 1,38x | 1,86x | 1,75x | 1,62x | 1,17x | 1,09x | 1,01x |
EV / EBITDA |
10,8x | 6,05x | 8,40x | 7,65x | 8,22x | 6,82x | 5,93x | 5,13x |
Price to Book |
2,74x | 1,48x | 1,67x | 1,78x | 1,32x | 0,83x | 0,79x | 0,74x |
Nbr of stocks (in thousands) |
306 740 | 306 845 | 298 249 | 292 869 | 292 994 | 293 413 | - | - |
Reference price (EUR) |
87,8 | 56,6 | 66,0 | 68,2 | 57,1 | 36,7 | 36,7 | 36,7 |
Announcement Date |
02/26/2018 | 02/20/2019 | 02/20/2020 | 02/23/2021 | 02/22/2022 | - | - | - |
1 EUR in Million |
|
|
Income Statement Evolution (Annual data) |
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net sales1 |
17 784 | 16 547 | 17 477 | 17 859 | 17 619 | 19 086 | 20 081 | 21 076 |
EBITDA1 |
3 098 | 3 763 | 3 863 | 4 090 | 3 476 | 3 270 | 3 690 | 4 148 |
Operating profit (EBIT)1 |
2 362 | 3 038 | 2 270 | 2 304 | 1 852 | 1 566 | 1 959 | 2 322 |
Operating Margin |
13,3% | 18,4% | 13,0% | 12,9% | 10,5% | 8,21% | 9,75% | 11,0% |
Pre-Tax Profit (EBT)1 |
2 008 | 2 737 | 1 841 | 1 936 | 1 572 | 1 279 | 1 672 | 1 982 |
Net income1 |
1 280 | 1 982 | 1 200 | 1 164 | 969 | 700 | 1 027 | 1 274 |
Net margin |
7,20% | 12,0% | 6,87% | 6,52% | 5,50% | 3,67% | 5,11% | 6,04% |
EPS2 |
4,17 | 6,47 | 3,96 | 3,96 | 3,31 | 2,32 | 3,42 | 4,24 |
Dividend per Share2 |
0,96 | 1,17 | 1,20 | 1,34 | 1,35 | 1,10 | 1,26 | 1,44 |
Announcement Date |
02/26/2018 | 02/20/2019 | 02/20/2020 | 02/23/2021 | 02/22/2022 | - | - | - |
1 EUR in Million 2 EUR |
|
|
Income Statement Evolution (Quarterly data) |
|
Fiscal Period: December
|
2018 S1 |
2020 Q1 |
2020 Q2 |
2020 Q3 |
2020 Q4 |
2021 Q1 |
2021 Q2 |
2021 Q3 |
2021 Q4 |
2022 Q1 |
2022 Q2 |
2022 Q3 |
2022 Q4 |
Net sales1 |
8 189 | 4 488 | 4 557 | 4 414 | 4 400 | 4 210 | 4 320 | 4 441 | 4 647 | 4 548 | 4 757 | 4 725 | 4 933 |
EBITDA1 |
- | 956 | 1 061 | 1 025 | 1 043 | 862 | 811 | 907 | 895 | 767 | - | 811 | 828 |
Operating profit (EBIT)1 |
1 898 | 555 | 656 | 632 | 462 | 474 | 424 | 505 | 449 | 348 | 341 | 395 | 399 |
Operating Margin |
23,2% | 12,4% | 14,4% | 14,3% | 10,5% | 11,3% | 9,82% | 11,4% | 9,67% | 7,65% | 7,17% | 8,36% | 8,10% |
Pre-Tax Profit (EBT) |
- | 451 | 564 | 544 | - | 398 | 355 | 436 | 382 | 279 | - | - | - |
Net income1 |
- | 283 | 351 | 354 | 177 | 249 | 219 | 273 | 229 | 157 | 147 | 185 | 163 |
Net margin |
- | 6,31% | 7,70% | 8,01% | 4,03% | 5,91% | 5,06% | 6,15% | 4,92% | 3,45% | 3,09% | 3,91% | 3,30% |
EPS2 |
4,15 | 0,95 | 1,20 | 1,21 | 0,61 | 0,85 | 0,75 | 0,93 | 0,78 | 0,54 | 0,50 | 0,63 | 0,55 |
Dividend per Share |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date |
07/31/2018 | 05/06/2020 | 07/30/2020 | 10/29/2020 | 02/23/2021 | 05/06/2021 | 07/30/2021 | 11/02/2021 | 02/22/2022 | 05/04/2022 | 07/28/2022 | - | - |
1 EUR in Million 2 EUR |
|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net Debt1 |
6 470 | 5 400 | 12 775 | 11 298 | 11 838 | 11 545 | 11 115 | 10 520 |
Net Cash position1 |
- | - | - | - | - | - | - | - |
Leverage (Debt / EBITDA) |
2,09x | 1,44x | 3,31x | 2,76x | 3,41x | 3,53x | 3,01x | 2,54x |
Free Cash Flow1 |
1 247 | 1 005 | 1 442 | 3 197 | 1 660 | 1 429 | 1 654 | 1 830 |
ROE (Net Profit / Equities) |
12,9% | 18,4% | 11,5% | 11,7% | 7,37% | 6,42% | 8,10% | 9,35% |
Shareholders' equity1 |
9 899 | 10 789 | 10 394 | 9 927 | 13 159 | 10 909 | 12 681 | 13 626 |
ROA (Net Profit / Asset) |
5,17% | 7,89% | 4,06% | 3,60% | 2,93% | 2,18% | 2,58% | 3,45% |
Assets1 |
24 764 | 25 134 | 29 589 | 32 308 | 33 038 | 32 150 | 39 866 | 36 886 |
Book Value Per Share2 |
32,0 | 38,3 | 39,5 | 38,3 | 43,3 | 44,3 | 46,6 | 49,6 |
Cash Flow per Share2 |
7,13 | 6,73 | 8,48 | 14,4 | 8,50 | 6,81 | 8,28 | 9,35 |
Capex1 |
944 | 1 057 | 1 125 | 1 036 | 829 | 1 121 | 1 205 | 1 267 |
Capex / Sales |
5,31% | 6,39% | 6,44% | 5,80% | 4,71% | 5,88% | 6,00% | 6,01% |
Announcement Date |
02/26/2018 | 02/20/2019 | 02/20/2020 | 02/23/2021 | 02/22/2022 | - | - | - |
1 EUR in Million 2 EUR |
|
| |
|
|
U.S. Supreme Court rules against DaVita over dialysis coverage |
Capitalization (EUR) |
10 753 602 905 |
Capitalization (USD) |
11 025 943 715 |
Net sales (EUR) |
17 618 685 000 |
Net sales (USD) |
18 064 887 727 |
Number of employees |
123 153 |
Sales / Employee (EUR) |
143 063 |
Sales / Employee (USD) |
146 687 |
Free-Float |
67,9% |
Free-Float capitalization (EUR) |
7 304 747 004 |
Free-Float capitalization (USD) |
7 489 743 673 |
Avg. Exchange 20 sessions (EUR) |
40 533 319 |
Avg. Exchange 20 sessions (USD) |
41 559 847 |
Average Daily Capital Traded |
0,38% |
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
|